Search clinical trials for: Allowed third antiretroviral agent

Total 1027 results

Gilead Sciences

Completed

Switch Study to Evaluate F/TAF in HIV-1 Positive Participants Who Are Virologically Suppressed on Regimens Containing FTC/TDF

HIV-1 Infection

United States, United Kingdom, Canada, France, Italy, Puerto Rico, Belgium
Gilead Sciences

Completed

Safety and Efficacy of Switching From Regimens of ABC/3TC + a 3rd Agent to E/C/F/TAF Fixed-Dose Combination (FDC) in Virologically-Suppressed HIV 1 Infected Adults

HIV-1 Infection

Spain, United Kingdom, France, Germany, United States, Italy
French National Agency for Research on AIDS and...
National Institutes of Health (NIH)

Completed

Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)

HIV Infection | Tuberculosis

Cambodia
ViiV Healthcare
GlaxoSmithKline

Completed

Fractures Stratified by HIV and Antiretroviral Therapy (ART) Status

Infection, Human Immunodeficiency Virus | Fracture
Azienda Ospedaliero Universitaria Maggiore della...

Recruiting

Phenotyping Patients With Type 2 Diabetes Mellitus and Cancer (TCPT2023)

Diabetes Mellitus, Type 2 | Cancer

Italy
Sanjay Mohan
AbbVie; Karyopharm Therapeutics Inc

Active, not recruiting

Venetoclax and Selinexor in Treating Patients With Relapsed or Refractory High Risk Hematologic Malignancies

Acute Myeloid Leukemia | Non-Hodgkin's Lymphoma | Diffuse Large B-cell Lymphoma

United States
ANRS, Emerging Infectious Diseases

Unknown

Cohorte Nationale VIH-2 (ANRS CO VIH2)

HIV-2 Infection

France
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France

Active, not recruiting

Reducing Antiretroviral Treatments (ALTAR)

HIV-1-infection

France
Centers for Disease Control and Prevention
The AIDS Support Organization; British Medical Research Council

Completed

Comparison of Facility and Home-based ART Delivery Systems in Uganda

AIDS

Uganda
Rockefeller University
Aaron Diamond AIDS Research Center

Completed

Observational Study of Treated and Untreated Acute and Early HIV-1 Infection

HIV Infections

United States
Gilead Sciences

Completed

Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants (BRAAVE 2020)

HIV-1 Infection

United States
Janssen-Cilag Farmaceutica Ltda.

Completed

A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1

HIV

Portugal
Juan A. Arnaiz

Completed

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression (OLE)

HIV Infection

Spain
Women's College Hospital
Canadian Institutes of Health Research (CIHR)

Completed

Study of Pharmacokinetics in HIV-infected Women

HIV Infections

Canada
Centre Hospitalier Universitaire de Nīmes

Completed

Role of Reverse Transcriptase Inhibitors in the Treatment of Psoriasis (PSORTI-BIO)

Psoriasis

France
National Center for Research Resources (NCRR)
Elizabeth Glaser Pediatric AIDS Foundation

Completed

The Metabolic Effects of Protease Inhibitors in HIV Infected Children

HIV Infections

United States
Hospices Civils de Lyon

Completed

Impact of CMV Status on HIV Viral Load Decay

Hiv

France
Objectif Recherche Vaccins SIDA
Fondation Bettencourt-Schueller

Completed

Towards HIV Functional Cure (ULTRASTOP)

Chronic HIV-1 Infection

France
Göteborg University
Sahlgrenska University Hospital, Sweden

Completed

Third Stage of Labor a Swedish Randomized Controlled Trial

Childbirth
Pfizer

Completed

Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes

Diabetes Mellitus

United States, Puerto Rico
I.M. Sechenov First Moscow State Medical University

Not yet recruiting

Use of Erbium Laser for Extraction of the Third Molars

Impacted Third Molar Tooth | Third Molar Extraction
University of Washington
National Institute of Mental Health (NIMH)

Recruiting

HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV (HeadStART)

HIV Infections | Hiv

Uganda
Peking Union Medical College Hospital

Completed

Gut Microbiota Changes of HIV Patients Before and After One Year of ART

HIV Infections

China
Duke University
Janssen, LP

Completed

Obesity in HIV After Antiretroviral Therapy

Obesity | HIV | AIDS

United States
MSD Pharmaceuticals LLC

Completed

ART First-line Treatment Durability in Russia

HIV-1-infection

Russian Federation
David Garcia Cinca
Fundacion Clinic per a la Recerca Biomédica

Unknown

Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection (VIRECURE)

HIV Infections

Spain
National Institute of Allergy and Infectious Diseases...
Community Programs for Clinical Research on AIDS

Completed

Effects of Two Anti-HIV Drug Regimens on Quality of Life and Health Care Use Among SMART Study Participants

HIV Infections

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study in Adults With Type 1 Diabetes (ELEMENT 1)

Diabetes Mellitus, Type 1

Japan, United States, Greece, Belgium, Poland, Germany, Hungary, Mexico, Romania
AbbVie

Available

Expanded Access to Venetoclax

Multiple Myeloma | Non-Hodgkin's Lymphoma | Amyloidosis | Chronic Lymphocytic Leukemia (CLL) | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | Plasma Cell Leukemia
University of Minnesota
National Health and Medical Research Council, Australia; Bristol-Myers Squibb; National Institutes of Health Clinical Center (CC) and other collaborators

Completed

Strategic Timing of Antiretroviral Treatment (START)

HIV Infection

Spain, United States, United Kingdom, Ireland, Australia, Argentina, Denmark, Sweden, Israel, Switzerland, Germany, Brazil, Norway, Chile, Thailand, Peru, Portugal, Greece, Luxembourg, Uganda, Austria, Belgium, Czechia, Estonia, Finland, ... and more
Yale University

Completed

Directly Observed Therapy for Community-Released HIV+ Prisoners (Connect)

HIV/AIDS | Substance Abuse

United States
American Gene Technologies International Inc.

Enrolling by invitation

An Antiretroviral Treatment Interruption (ATI) Study to Evaluate the Impact of Genetically Modified Autologous Cells (AGT103-T) to Suppress Human Immunodeficiency Virus Replication in the Absence of Antiretroviral Therapy

HIV

United States
Yale University

Completed

Directly Observed Antiretroviral Therapy Among Active Drug Users

HIV/AIDS | Substance Abuse

United States
Botswana-UPenn Partnership
University of Pennsylvania; Doris Duke Charitable Foundation

Completed

Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis (Crypto)

HIV Infections | Cryptococcal Meningitis

Botswana
National Institute of Allergy and Infectious Diseases...

Withdrawn

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

HIV Infections

United States, Puerto Rico
United BioPharma

Not yet recruiting

UB-421 in Combination With Optimized Background Regimen in Patients With Multi-drug Resistant HIV-1 Infection

HIV-1 Infection
Johns Hopkins Bloomberg School of Public Health
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Anti-HIV Medications for People Recently Infected With HIV

HIV Infections

United States, Canada
International Maternal Pediatric Adolescent AIDS...
National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy...

Completed

IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women

HIV Infection

United States, Argentina, Botswana, Brazil, China, Haiti, Peru, Puerto Rico, Thailand
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Completed

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

HIV Infections

United States, Puerto Rico
French National Agency for Research on AIDS and...

Terminated

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

HIV Infections

France
French National Agency for Research on AIDS and...
Merck Sharp & Dohme LLC; Gilead Sciences

Completed

Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO) (TEMPRANO)

HIV Infections | Tuberculosis

Côte D'Ivoire
Hoffmann-La Roche

Recruiting

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

Spain, Australia, Germany, United States, Italy, United Kingdom, France
Universitätsklinikum Hamburg-Eppendorf

Completed

Immediate Versus Deferred Antiretroviral Therapy in HIV-infected Patients Presenting With Acute AIDS-defining Events (IDEAL)

HIV-Infection

Germany
University of North Carolina, Chapel Hill
Doris Duke Charitable Foundation

Completed

Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia

HIV Infections

Zambia
University of Cape Town
London School of Hygiene and Tropical Medicine; Medical Research Council, South... and other collaborators

Unknown

Effect of Public Sector Antiretroviral Treatment Programme on Tuberculosis and Immunization Care

Tuberculosis

South Africa
Kanuni Sultan Suleyman Training and Research Hospital

Completed

Uterine Massage After Vaginal Delivery

Postpartum Hemorrhage

Turkey
Novartis Pharmaceuticals

Completed

French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients

Chronic Myeloid Leukemia

France
Lund University
Ethiopian Public Health Institute; Armauer Hansen Research Institute, Ethiopia and other collaborators

Recruiting

HIV Transmission in the Era of Scaling up Antiretroviral Therapy in Ethiopia (THESA)

Antiretroviral Therapy | HIV-1-infection

Ethiopia
National Institute of Allergy and Infectious Diseases...

Withdrawn

Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV

HIV Infections
Institut de Recherche pour le Developpement
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand

HIV Infections

Thailand

Search clinical trials for: Allowed third antiretroviral agent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations